Segui
Fabiana Tatangelo
Fabiana Tatangelo
M.D., Pathology Department, Istituto Nazionale Tumori - IRCCS - Fondazione G.Pascale - Napoli, Italia
Email verificata su istitutotumori.na.it
Titolo
Citata da
Citata da
Anno
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pags, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...
The Lancet 391 (10135), 2128-2139, 2018
18422018
Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours
J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ...
The Journal of pathology 232 (2), 199-209, 2014
14912014
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...
Nature medicine 21 (7), 795, 2015
11072015
Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pags, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ...
Journal of translational medicine 10 (1), 205, 2012
9582012
18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer
GL Cascini, A Avallone, P Delrio, C Guida, F Tatangelo, P Marone, L Aloj, ...
Journal of Nuclear Medicine 47 (8), 1241-1248, 2006
2622006
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
A Ottaiano, R Franco, AA Talamanca, G Liguori, F Tatangelo, P Delrio, ...
Clinical cancer research 12 (9), 2795-2803, 2006
2512006
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro
Genomics 102 (2), 74-83, 2013
1862013
Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis
G Nardone, A Rocco, D Vaira, S Staibano, A Budillon, F Tatangelo, ...
The Journal of pathology 202 (3), 305-312, 2004
1422004
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
N Normanno, AM Rachiglio, M Lambiase, E Martinelli, F Fenizia, ...
Annals of oncology 26 (8), 1710-1714, 2015
1362015
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial
F Ciardiello, N Normanno, E Maiello, E Martinelli, T Troiani, S Pisconti, ...
Annals of oncology 25 (9), 1756-1761, 2014
1342014
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells
A Ottaiano, A di Palma, M Napolitano, C Pisano, S Pignata, F Tatangelo, ...
Cancer Immunology, Immunotherapy 54 (8), 781-791, 2005
1262005
CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors
A Rocco, E Liguori, G Pirozzi, V Tirino, D Compare, R Franco, F Tatangelo, ...
Journal of cellular physiology 227 (6), 2686-2693, 2012
1002012
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy
M Colombino, P Sperlongano, F Izzo, F Tatangelo, G Botti, A Lombardi, ...
Cell death & disease 3 (1), e259, 2013
962013
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma
AM Rachiglio, RE Abate, A Sacco, R Pasquale, F Fenizia, M Lambiase, ...
Oncotarget 7 (41), 66595, 2016
942016
Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade
V Granata, R Fusco, O Catalano, B Guarino, F Granata, F Tatangelo, ...
Oncotarget 7 (48), 79357, 2016
912016
Analysis of APAF‐1 expression in human cutaneous melanoma progression
A Baldi, D Santini, P Russo, C Catrical, A Amantea, M Picardo, ...
Experimental dermatology 13 (2), 93-97, 2004
882004
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX
F Ciardiello, N Normanno, E Martinelli, T Troiani, S Pisconti, C Cardone, ...
Annals of Oncology 27 (6), 1055-1061, 2016
872016
Hepatic arterial embolization in patients with neuroendocrine tumors
M Del Prete, F Fiore, R Modica, V Marotta, F Marciello, V Ramundo, ...
Journal of Experimental & Clinical Cancer Research 33 (1), 43, 2014
802014
Extra-mitochondrial localisation of frataxin and its association with IscU1 during enterocyte-like differentiation of the human colon adenocarcinoma cell line Caco-2
F Acquaviva, I De Biase, L Nezi, G Ruggiero, F Tatangelo, C Pisano, ...
Journal of cell science 118 (17), 3917-3924, 2005
752005
Upper limb function and quality of life in breast cancer related lymphedema: a cross-sectional study
M Pinto, F Gimigliano, F Tatangelo, M Megna, F Izzo, R Gimigliano, ...
Eur J Phys Rehabil Med 49 (5), 665-73, 2013
702013
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20